BioSpace News Archive

ExoCoBio Inc. announced that it recently raised $9.3 million in its series C and Pre-IPO funding. For this round, return VCs of K2 Investment Partners, SBI Investment Korea, and Dt & Investment were joined by new comers G.N.Tech/ReeHu Investment and Focus Assets Management.

The access information for the investor conference call remains as follows: Direct Toll / International – 1-(866) 831-8711 Domestic US/Canada - 1-(203) 518-9883 Program Title: Generex Biotechnology Conference Call Conference ID – 89636 Updated Agenda FDA response to Pre-IND briefing package for Ii-Key-SARS-CoV-2 vaccine Meeting with the Canadian National Research Council to discuss moving the Ii-Key-SARS-CoV-2 vaccine technology forward Completed the deal with Worldwide Digitech, LLC (

Today, Clover Health, an innovative technology company improving health outcomes for America’s seniors, announced it joined a group of the largest insurers in the United States as a part of the U.S. Food and Drug Administration’s (FDA) Early Payor Feedback Program

Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of rare primary and metastatic cancers, today announced management will present at the LD Micro 500 Virtual Conference Tuesday, September 01, 2020 3:00 PM ET. A live webcast of the presentation will be available to the public at https://www.webcaster4.com/Webcast/Page/2019/36399 . The webcast will be archived for 90 days following the liv

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended June 30, 2020. Recent Highlights Total revenue of $10.6 million including four platform placements Completed initial public offering, raising approximately $188 million of net proceeds Second Quarter 2020 Financial Results Revenue was $10.6 million for the quarter ended June 30, 2020, representing a 10% d

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system, today announced the closing of its upsized initial public offering of 9,987,520 common shares, including the exercise in full by the underwriters of their option to purchase up to 1,302,720

Kannalife, Inc. announced that the Company has been issued patents in Austria, Luxembourg, Liechtenstein, and the Principality of Monaco for its patent known as WO2015/106108A2 titled, “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy”.

The Parkinson’s Foundation today announced expanded virtual programs to support the Parkinson’s disease (PD) community during the ongoing COVID-19 pandemic. Fall Moving Day events, the Foundation’s signature fundraising walk event will take place online in 18 cities across the country. Additionally, the Foundation will offer n

Medela has been awarded a group purchasing agreement for Suction Canisters Yankauers with Premier Inc. Effective August 1, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for airway suction device and virus filters.

Team of second-generation pharmacy owners continues nationwide expansion of digital pharmacy services, with same-day, contactless delivery for necessary medications